Biotechnology News

カリフォルニア州アラメダ発 , July 08, 2026 (GLOBE NEWSWIRE) --  新規の超長時間作用型薬剤インプラントを開発する革新的なバイオ医薬品企業、ヴィヴァニ・メディカル (Vivani Medical, Inc.) (NASDAQ: VANI) (以下「ヴィヴァニ」または「同社」) は本日、ノボ ノルディスク (Novo Nordisk)...

เมืองอลาเมดา รัฐแคลิฟอร์เนีย, July 08, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” หรือ “บริษัท”)...

미국 캘리포니아주 알라메다, July 08, 2026 (GLOBE NEWSWIRE) -- 혁신적인 초장기 지속형 약물 임플란트를 개발하는 바이오의약품 기업 Vivani Medical, Inc.(나스닥: VANI)는 Novo Nordisk와 새로운 계약을 체결했다고 밝혔다. 이번 계약에 따라 Novo Nordisk는 Vivani가 개발 중인...

ALAMEDA, California, July 08, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” atau “Syarikat”), sebuah syarikat biofarmaseutikal inovatif yang membangunkan implan ubat jangka...

TAIPEI, July 07, 2026 (GLOBE NEWSWIRE) -- TaiMed Biologics (TPEX: 4147) announced today that its HIV therapy Trogarzo (ibalizumab; English name: Trogarzo Injection; Chinese name: 佐加洛注射劑) has...

Richard Lowenthal, Chief Executive Officer, Transitioning following More than a Decade of Leadership Since Co-Founding the Company Donn Casale, President, Appointed Chief Executive Officer and...

CAMBRIDGE, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- As previously announced, Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of...

BOSTON, July 07, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of David...

Mechelen, Belgium; 07 July 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT)...

Mechelen, België; 07 juli 2026, 22.01 CET; gereglementeerde informatie In het kader van het op 9 juni 2026 aangekondigde inkoopprogramma maakt Lakefront Biotherapeutics NV (Euronext & NASDAQ:...